Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NVS - Idorsia Is Likely Set For A Short Squeeze

NVS - Idorsia Is Likely Set For A Short Squeeze

Novartis AG
  • QUVIVIQ (Daridorexant) and PIVLAZ (Clazosentan) are now commercialized by Idorisa, and Johnson & Johnson is distributing Ponvory (Ponesimod).
  • The Swiss and Canadian health authorities are supposed to give their feedback on QUVIVIQ very soon.
  • The stock price has been repeatedly and systematically selling off after a positive catalyst, and every breakout tentative has been pushed back.
  • The stock price is seen with 78% upside potential, and under the observed actual conditions I consider a short squeeze very likely.

For further details see:

Idorsia Is Likely Set For A Short Squeeze
Stock Information
Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com
Menu
NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...